High Vista Strategies LLC Sage Therapeutics, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $554,891 - $801,701	-10,111 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $30,379 - $41,606	430 Added 4.44%	10,111 $757,000
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $29,146 - $44,440	499 Added 5.43%	9,681 $838,000
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $377,655 - $573,415	9,182 New	9,182 $561,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $284M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.